ResMed Inc. (RSMDF)
OTCMKTS · Delayed Price · Currency is USD
25.85
-0.31 (-1.17%)
Oct 31, 2025, 4:00 PM EDT
ResMed Employees
ResMed had 10,600 employees as of June 30, 2025. The number of employees increased by 620 or 6.21% compared to the previous year.
Employees
10,600
Change (1Y)
620
Growth (1Y)
6.21%
Revenue / Employee
$495,981
Profits / Employee
$135,651
Market Cap
36.04B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 10,600 | 620 | 6.21% |
| Jun 30, 2024 | 9,980 | -160 | -1.58% |
| Jun 30, 2023 | 10,140 | 1,980 | 24.26% |
| Jun 30, 2022 | 8,160 | 190 | 2.38% |
| Jun 30, 2021 | 7,970 | 200 | 2.57% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Jushi Holdings | 1,234 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |
ResMed News
- 2 days ago - RMD: RBC Capital Raises Price Target, Maintains Outperform Rating | RMD Stock News - GuruFocus
- 2 days ago - Keybanc Analyst Raises ResMed (RMD) Price Target to $299 | RMD Stock News - GuruFocus
- 2 days ago - Mizuho Maintains 'Outperform' for RMD but Lowers Price Target | RMD Stock News - GuruFocus
- 2 days ago - These Analysts Revise Their Forecasts On ResMed Following Q1 Results - Benzinga
- 2 days ago - These Analysts Revise Their Forecasts On ResMed Following Q1 Results - Benzinga
- 2 days ago - ResMed declares $0.60 dividend - Seeking Alpha
- 2 days ago - Resmed Stock Up on Q1 Earnings & Revenue Beat, Margins Expand - Nasdaq
- 2 days ago - ResMed Inc. 2026 Q1 - Results - Earnings Call Presentation - Seeking Alpha